News
Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past? CanSino Biologics, Johnson & Johnson, and the University of Oxford are all using genetically ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback